Stem Cells therapy
Human iPSC-derived MSCs from aged individuals acquire a rejuvenation signature
Human iPSC-derived MSCs from aged individuals acquire a rejuvenation signature The use of primary mesenchymal stem cells (MSCs) is fraught with ageing-related shortfalls such as limited expansion and early senescence. Human induced pluripotent stem cells (iPSCs) -derived MSCs (iMSCs) have been shown to be a useful clinically relevant source Read more…